Page 251 - Read Online

Depboylu et al. Vessel Plus 2018;2:26 I http://dx.doi.org/10.20517/2574-1209.2018.39 Page 11 of 11

Tchetche D, Abdel-Wahab M, De Marco F, Baumbach A, Laborde JC, Kornowski R. Transcatheter aortic valve replacement for degen-
erative bioprosthetic surgical valves: results from the global valve-in valve registry. Circulation 2012;126:2335-44.
26. Paradis JM, Del Trigo M, Puri R, Rodés-Cabau J. Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical
prosthetic dysfunction. J Am Coll Cardiol 2015;66:2019-37.
27. Ribeiro HB, Nombela-Franco L, Urena M, Mok M, Pasian S, Doyle D, DeLarochellière R, Côté M, Laflamme L, DeLarochellière H,
Allende R, Dumont E, Rodés-Cabau J. Coronary obstruction following transcatheter aortic valve implantation: a systematic review.
JACC Cardiovasc Interv 2013;6:452-61.
28. Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, Zachow D, Guerra E, Massberg S, Schäfer U, El-Mawardy M,
Richardt G; CHOICE investigators. Comparison of balloon-expandable versus self-expandable valves in patients undergoing transcath-
eter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014;311:1503-14.
29. Rodés-Cabau J, Gutiérrez M, Bagur R, De Larochellière R, Doyle D, Côté M, Villeneuve J, Bertrand OF, Larose E, Manazzoni J, Pibar-
ot P, Dumont E. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic
valve implantation. J Am Coll Cardiol 2011;57:1988-99.
30. Miller DC, Blackstone EH, Mack MJ, Svensson LG, Kodali SK, Kapadia S, Rajeswaran J, Anderson WN, Moses JW, Tuzcu EM, Webb
JG, Leon MB, Smith CR; PARTNER Trial Investigators and Patients; PARTNER Stroke Substudy Writing Group and Executive Com-
mittee. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of
neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg 2012;143:832-43.
31. Stortecky S, Windecker S, Pilgrim T, Heg D, Buellesfeld L, Khattab AA, Huber C, Gloekler S, Nietlispach F, Mattle H, Jüni P, Wenawe-
ser P. Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. Euro-
Intervention 2012;8:62-70.
32. Nombela-Franco L, Webb JG, de Jaegere PP, Toggweiler S, Nuis RJ, Dager AE, Amat-Santos IJ, Cheung A, Ye J, Binder RK, van der
Boon RM, Van Mieghem N, Benitez LM, Pérez S, Lopez J, San Roman JA, Doyle D, Delarochellière R, Urena M, Leipsic J, Dumont
E, Rodés-Cabau J. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing
transcatheter aortic valve implantation. Circulation 2012;126:3041-53.
33. Van Mieghem NM, Schipper ME, Ladich E, Faqiri E, van der Boon R, Randjgari A, Schultz C, Moelker A, van Geuns RJ, Otsuka F,
Serruys PW, Virmani R, de Jaegere PP. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circu-
lation 2013;128:e478-9.
34. Grube E, Naber C, Abizaid A, Sousa E, Mendiz O, Lemos P, Kalil Filho R, Mangione J, Buellesfeld L. Feasibility of transcatheter aortic
valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv 2011;4:751-7.
35. Rezq A, Basavarajaiah S, Latib A, Takagi K, Hasegawa T, Figini F, Cioni M, Franco A, Montorfano M, Chieffo A, Maisano F, Corvaja
N, Alfieri O, Colombo A. Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation: a
single-center study. JACC Cardiovasc Interv 2012;5:1264-72.
36. Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, García-García H, Schultz C, van Domburg R, van Es GA, van Geuns R, de Jaegere P,
Serruys PW. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implanta-
tion. EuroIntervention 2010;6:475-84.
37. Roten L, Wenaweser P, Delacrétaz E, Hellige G, Stortecky S, Tanner H, Pilgrim T, Kadner A, Eberle B, Zwahlen M, Carrel T, Meier
B, Windecker S. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J
Cardiol 2010;106:1473-80.
38. Bates MG, Matthews IG, Fazal IA, Turley AJ. Postoperative permanent pacemaker implantation in patients undergoing trans-catheter
aortic valve implantation: what is the incidence and are there any predicting factors? Interact Cardiovasc Thorac Surg 2011;12:243-53.
39. Nazif TM, Dizon JM, Hahn RT, Xu K, Babaliaros V, Douglas PS, El-Chami MF, Herrmann HC, Mack M, Makkar RR, Miller DC,
Pichard A, Tuzcu EM, Szeto WY, Webb JG, Moses JW, Smith CR, Williams MR, Leon MB, Kodali SK; PARTNER Publications Of-
fice. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER
(Placement of AoRticTraNscathetER Valves) trial and registry. JACC Cardiovasc Interv 2015; 8:60-9.
40. Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, Cheng J, Piazza N, van Domburg RT, Serruys
PW, de Jaegere PP. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreV-
alve System in patients with aortic stenosis. Eur Heart J 2011;32:2067-74.
41. Colombo A, Latib A. Left bundle branch block after transcatheter aortic valve implantation: inconsequential or a clinically important
endpoint? J Am Coll Cardiol 2012;60:1753-5.
42. Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T; All-Literature Investigation of Cardiovascular Evidence Group. Incidence, predic-
tors, and prognosis of acute kidney injury after transcatheter aortic valve implantation: a summary of contemporary studias using Valve
Academic Research Consortium definations. Int J Cardiol 2013;168:1631-5.
43. Van Mieghem NM, van der Boon RM, Nuis RJ, Schultz C, van Geuns RJ, Serruys PW, Kappetein AP, van Domburg RT, de Jaegere PP.
Cause of death after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2014;83:E277-82.